Skip to search formSkip to main contentSkip to account menu

fengabine

Known as: 2-(N-butyl-o-chlorobenzimidoyl)-4-chlorophenyl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryGamma-aminobutyric acid (GABA) and GABA agonists exhibited biphasic response on forced swimming-induced despair behavior… 
1993
1993
1. The effects of fengabine were compared with those of amitriptyline in healthy elderly volunteers. Doses were administered… 
1991
1991
A double‐blind controlled trial of Fengabine, a GABA agonist, against placebo was carried out in outpatient major depressives… 
1990
1990
The possible involvement of gamma-aminobutyric acid/benzodiazepine (GABA-BZ) receptor modulation in scopolamine-induced short… 
1990
1990
The results of a double‐blind clinical trial of fengabine vs clomipramine in depressed outpatients are reported. Fengabine, a new… 
Review
1989
Review
1989
Fengabine is a new GABAmimetic compound active in animal models predictive of antidepressant activity. The present overview… 
Review
1989
Review
1989
Evidence suggests the involvement of the GABAergic (γ-aminobutyric acid) system in affective disorders and the therapeutic action… 
1987
1987
The effects of fengabine (a novel benzylidene derivative possessing clinically demonstrated antidepressant action) on… 
1987
1987
Fengabine (SL 79.229) is a novel benzylidene derivative with clinically proven antidepressant action. Fengabine is active in… 
Review
1987
Review
1987
Recently sufficient evidence has accumulated to propose that a central GABAergic dysfunction may be primarily related to the…